Tromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology

Clinical and Experimental Obstetrics and Gynecology

Volumn 29, Issue 4, 2002, Pages 267-270

  Tzafettas, J ^a,b,c   Mamopoulos, A ^a   Anapliotis, A ^b   Loufopoulos, A ^b   Psarra, A ^a   Klearchou, N ^a   Mamopoulos, M ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b Blue Cross IVF/Infertility Centre   (Greece)

^c NONE   (Greece)

Author keywords

Recurrent miscarriages; Thromboprophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; SALOSPIR; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMATOMA; HUMAN; IDIOPATHIC DISEASE; INJECTION SITE; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; OUTCOMES RESEARCH; PREECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; RECURRENT ABORTION; SKIN MANIFESTATION; SOLUTIO PLACENTAE; THROMBOPHILIA; THROMBOSIS PREVENTION; COHORT ANALYSIS; DRUG ADMINISTRATION; EVALUATION; FIRST TRIMESTER PREGNANCY; PREGNANCY COMPLICATION; TREATMENT OUTCOME;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; ASPIRIN; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 0036987678     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ACOG practice bulletin. Management of recurrent pregnancy loss. 2001, 24, 1.
2. Harris E. N.: "Syndrome of the black swan". Br. J. Rheumatol., 1987, 26, 324.
3. Branch D. W., Andres R., Digre K. B., Rote N. S., Scott J. R.: "The association of antiphospholipid antibodies with severe pre-eclampsia". Obstet. Gynecol., 1989, 73, 541.
4. Lockshin M. D., Druzin M. L., Goei S. et al.: "Antibody to cardiolipin as a predictor of fetal distress or death in pregnancy patients with systemic lupus erythematosous". N. Engl. J. Med., 1985, 313, 1526.
5. Birdsall M., Pattison N., Chamley N.: "Antiphospholipid antibodies in pregnancy". Aust. N. Z. J. Obstet. Gynaecol., 1992, 32, 328.
6. Rai R. S., Regan L., Clifford K., Pickering W., Dave M., Mackie I. et al.: "Antiphospholipid antibodies and β2-glycoprotein-1 in 500 women with recurrent miscarriage: results of a comprehensive screening approach". Hum. Reprod., 1995, 10, 101.
7. Lockwood C. J., Romero R., Clyne L. P., Coster B. and Hobbins J. C.: "The prevalence of biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population". Am. J. Obstet. Gynecol., 1989, 161, 369.
8. Perez M. C., Wilson W. A., Brown H. L., Skopelitis E.: "Anticardiolipin antibodies in unselected pregnant women in relation to fetal outcome". J. Perinatol., 1991, 11, 33.
9. Martinelli I., Taioli E., Cetin I., Marinoni A., Gerosa S., Villa M. et al.: "Mutations in coagulation factors in women with unexplained late fetal loss". N. Engl. J. Med., 2000, 343, 1015.
10. Branch D. W., Scott J. R., and Kochenour N. K.: "Obstetric complications associated with lupus anticiagulant". N. Engl. J. Med., 1985, 32, 328.
11. Lubbe W. F., Liggins G. C.: "Lupus anticoagulant in pregnancy". Am. J. Obstet. Gynecol., 1985, 153, 322.
12. Barbui T., Cortelazzo S., Galli M. et al.: "Antiphospholipid antibodies in early repeated abortions: a case controled study". Fertil. Steril., 1988, 50, 589.
13. Rai R., Cohen H., Dave M., Regan L.: "Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies". Br. Med. J., 1997, 314, 253.
14. Khong T. W., Liddell H. S., Robertson W. B.: "Defective haemochorial placentation as a cause of miscariage: a preliminary study". Br. J. Obstet. Gynaecol., 1987, 94, 649.
15. Khong T. W., De Wolf F., Robertson W. B., Brosens I.: "Inadequate maternal vascular response to placentation in pregnanciew affected by pre-eclampsia and small for gestational age infants". Br. J. Obstet. Gynaecol., 1986, 93, 1049.
16. Chamley L. W., Pattison N. S., McKay E. J.: "Elution of anticardiolipin antibodies and their cofactor beta 2-glycoprotein 1 from the placentae of patients with a poor obstetric history". J. Reprod. Immunol., 1993, 25, 209.
17. Out H. J., Kooijman C. D., Bruise H. W., Derksen R. H.: "Histopathological findings in placentae from patients with intra-uterine ftal deathand anti-phoapholipd antibodies". Eur. J. Obstet. Gynecol. Reprod. Biol., 1991, 41, 179.
18. Tohgi H., Konno S., Tamura K., Kimura B., Kawano K.: "Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin". Stroke, 1992, 23, 1400.
19. Sanchez Guerrero J., Alarcon Segovia D.: "Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients". J. Reumatol., 1992, 19, 1083.
20. Beaufils M., Donsimoni R., Uzan S., Colau J. L.: "Prevention of pre-eclampsia by early antiplatelet therapy". Lancet, 1985, 1, 840.
21. Uzan S., Beaufils M., Breart G., Bazin B., Capitant C. and Paris: "Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial". Lancet, 1991, 1, 1427.
22. Lockshin M. D., Druzin M. L., Qamar T.: "Prednisone does not prevent recurrent fetral death in women with antiphospholipid antibody". Ant. J. Obstet. Gynecol., 1989, 160, 439.
23. Ensom M. H., Stevenson M. D.: "Low molecular-weight heparin in pregnancy". Pharmacotherapy, 1999, 9, 1013.
24. Kupferminc M. J., Eldor A., Steinnan N., Many A., Bar-Am A., Jaffa A., Fait G. and Lessins J. B.: "Increased frequency of genetic thrombophilia in women with complications of pregnancy". N. Engl. J. Med., 1999, 340, 9.
25. Mobray J. F., Gibbings C., Liddell H., Reginald P. W., Underwood J. L., Beard R. W.: "Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells". Lancet, 1985, 1 (8435), 941.
26. Ho H. N., Gill T. J., Jiang J. J., Lee T. Y., Hsieh C. Y.: "Immunotherapy or recurrent spontaneous abortion in a Chinese population". Am. J. Reprod. Immunol., 1991, 25, 10.
27. Cauchi M. N., Lim D., Young E., Kloss M., Pepperell R. J.: "Treatment of recurrent aborters-treatment with paternal cells-controlled trials". Am. J. Reprod. Immunol., 1991, 25, 16.
28. Gatenby P. A., Cameron K., Simes R. J., Adelstein S., Bennett M. J., Jansen R. P. et al.: "Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial". Am. J. Reprod. Immumol., 1993, 29, 88.
29. Speroff L., Glass R. H. and Kase N. G.: "Recurrent early pregnancy losses". In: "Clinical Gynecologic Endocrinology and Infertility Lippincott Williams & Wilkins", 1999, 27, 1043.
30. Clifford K., Rai R., Regan L.: "Future pregnancy outcome in unexplained recurrent first trimester miscarriage". Hum. Reprod., 1997, 12, 387.
31. Bar J., Mashiah R., Cohen-Sacher B., Hod M., Orviet R., Ben-Rafael Z. et al.: "Effect of thromboprophylaxis on uterine and fetal circulation in pregnanat women with a history of pregnancy complications". Thrombosis Res., 2001, 101, 235.
32. Melissari E., Parker C. J., Wilson N. V. et al.: "Use of low molecular weight heparin in pregnancy. Thrombosis and hemostasis". 1992, 68, 652.
33. Stray-Pedersen B., Stray-Pedersen S.: "Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion". Am. J. Obstet. Gynecol., 1984, 148, 140.